Syneos Health Releases 2024 Dealmakers' Intentions Survey
09 janv. 2024 07h00 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, today released its Dealmakers’ Intentions Survey. Conducted...
Syneos Health Dealmakers’ Intentions Survey Sees “Optimism” for M&A and Licensing Deals in 2023
10 janv. 2023 07h00 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 13th annual Dealmakers’...
Syneos Health Releases 2022 Dealmakers’ Intentions Survey
11 janv. 2022 09h00 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 12th annual Dealmakers’...